NCT05299242 - "The Anti-Freaze-F Study- Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study" | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 21, 2022

Primary Completion Date

May 9, 2023

Study Completion Date

June 12, 2023

Conditions

Frozen Shoulder

Interventions

DRUG

Adalimumab Injection

40mg in 0.8ml preparation in vials from Fresenius Kabi Ltd

DRUG

Placebo

Saline \[0.9% NaCl\]

Trial Locations (4)

Good Hope Hospital, Sutton Coldfield

Conquest Hospital, Saint Leonards-on-Sea

Grantham & District Hospital, United Lincolnshire Hospitals, Grantham

Sandwell General Hospital, West Bromwich